SCHEMBL4086191

SCHEMBL4086191

O=CNCc1ccc(Cl)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.42
ADH1B P00325 1/20 0.41
ADH1C P00326 1/20 0.41
ADH1A P07327 1/20 0.41
ADH7 P40394 1/20 0.41
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MMP8 P22894 3/20 0.37
MMP12 P39900 3/20 0.37
MMP13 P45452 3/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
GSK3B P49841 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13074361 0.78 FFAR1 (0.41) FFAR1KMT2AALDH1A1HTTRAB9A
SCHEMBL4096471 0.76 ADH1B (0.41) ADH1BADH1CADH1AADH7ALDH1A1
SCHEMBL2557730 0.73 MMP8 (0.45) FFAR1KMT2AALDH1A1HTTRAB9A
SCHEMBL12768200 0.73 FFAR1 (0.40) FFAR1KMT2AALDH1A1HTTRAB9A
SCHEMBL3844379 0.71 CYP1A2 (0.40) KMT2AALDH1A1SMN1; SMN2SLC6A3MEN1
SCHEMBL4090622 0.71 LOX (0.50) ADH1BADH1CADH1AADH7KMT2A
SCHEMBL15296332 0.68 FFAR1 (0.42) FFAR1KMT2AALDH1A1HTTRAB9A
SCHEMBL8671567 0.68 MMP8 (0.46) FFAR1KMT2AALDH1A1HTTRAB9A
SCHEMBL2820919 0.67 GSK3B (0.58) KMT2AALDH1A1RAB9AHPGDTSHR
SCHEMBL190205 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
EP-1861384-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2007-12-05 EP disclosed
WO-2006100502-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS STERIX LIMITED (GB) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors HSD3B1, HSD3B2, HSD11B1 FFAR1 394/4885ADH1B 127/4885ADH1C 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.